Menu
Recruiting NCT06885905

Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being

— Observational Chronic Pulmonary Aspergillosis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Chronic Pulmonary Aspergillosis. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.

Primary outcome measures

  • Impact of Chronic Pulmonary Aspergillosis (CPA) on health status and Well-being. [Time frame: 30 months]
Secondary outcome measures (2)
  • Impact of Chronic Pulmonary Aspergillosis (CPA) on health status and Well-being. [Time frame: 30 months]
  • Impact of Chronic Pulmonary Aspergillosis (CPA) on health status and Well-being. [Time frame: 30 months]

Eligibility criteria

Inclusion criteria

  • All patients >/= 18 years old and able to provide informed consent
  • Patients with a diagnosis of chronic pulmonary aspergillosis
  • To speak and understand English
  • Able to provide informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United Kingdom · 3 centers
  • Ninewells Hospital & Medical School — Dundee
  • Imperial College London — London
  • Manchester NHS Foundation Trust — Manchester

Identifiers

NCT: NCT06885905 · 23IC8471

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗